NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
+0.3%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.00 | -50.0% |
| 2024 | 0.00 | +184.3% |
| 2023 | 0.00 | -29.0% |
| 2022 | 0.00 | -91.1% |
| 2021 | 0.00 | - |
| 2020 | 0.00 | - |